Ramucirumab
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB05578 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | uterine ligament adenocarcinoma | KG + DL |
| 2 | endocervical carcinoma | KG + DL |
| 3 | adenoid cystic carcinoma of the cervix uteri | KG + DL |
| 4 | uterine ligament serous adenocarcinoma | KG + DL |
| 5 | signet ring cell variant cervical mucinous adenocarcinoma | KG + DL |
| 6 | cervical adenosquamous carcinoma, glassy cell variant | KG + DL |
| 7 | uterine ligament endometrioid adenocarcinoma | KG + DL |
| 8 | uterine ligament clear cell adenocarcinoma | KG + DL |
| 9 | uterine ligament mucinous adenocarcinoma | KG + DL |
| 10 | intestinal variant cervical mucinous adenocarcinoma | KG + DL |
| 11 | endocervical type cervical mucinous adenocarcinoma | KG + DL |
| 12 | cervical mucinous adenocarcinoma, minimal deviation variant | KG + DL |
| 13 | prostatic urethra urothelial carcinoma | KG + DL |
| 14 | kidney pelvis sarcomatoid transitional cell carcinoma | KG + DL |
| 15 | infiltrating bladder urothelial carcinoma sarcomatoid variant | KG + DL |
| 16 | renal pelvis papillary urothelial carcinoma | KG + DL |
| 17 | transitional cell carcinoma | KG + DL |
| 18 | squamous cell carcinoma of the corpus uteri | KG + DL |
| 19 | odontogenic cyst | KG + DL |
| 20 | mesonephric adenocarcinoma | KG + DL |
| 21 | nasopharyngeal teratoma | KG + DL |
| 22 | pre-malignant neoplasm | KG + DL |
| 23 | epiglottis neoplasm | KG + DL |
| 24 | tumor of testis and paratestis | KG + DL |
| 25 | non-seminomatous lesion | KG + DL |
| 26 | bronchial adenomas/carcinoids childhood | KG + DL |
| 27 | ductal or ductular proliferation | KG + DL |
| 28 | chondroid hamartoma | KG + DL |
| 29 | benign neoplasm of floor of mouth | KG + DL |
| 30 | cystic neoplasm | KG + DL |
| 31 | thyroglossal duct cyst | KG + DL |
| 32 | benign neoplasm of hypopharynx | KG + DL |
| 33 | cervical neuroblastoma | KG + DL |
| 34 | schwannoma of jugular foramen | KG + DL |
| 35 | angiosarcoma of the scalp | KG + DL |
| 36 | benign neoplasm of tongue | KG + DL |
| 37 | malignant ear neoplasm | KG + DL |
| 38 | inner ear neoplasm | KG + DL |
| 39 | trophoblastic neoplasm | KG + DL |
| 40 | nasal cavity inverting papilloma | KG + DL |
| 41 | mesenchymoma | KG + DL |
| 42 | vestibulocochlear nerve neoplasm | KG + DL |
| 43 | epidural spinal canal neoplasm | KG + DL |
| 44 | neoplasm of major salivary gland | KG + DL |
| 45 | jugular foramen meningioma | KG + DL |
| 46 | benign neoplasm of buccal mucosa | KG + DL |
| 47 | benign neoplasm of nasal cavity | KG + DL |
| 48 | ocular cancer | KG + DL |
| 49 | vagus nerve paraganglioma | KG + DL |
| 50 | benign neoplasm of oral cavity | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.